HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,230,631 | -68.9% | 105,719 | -72.3% | 0.03% | -67.1% |
| Q2 2023 | $39,301,968 | +797.8% | 382,129 | +852.7% | 0.08% | +844.4% |
| Q1 2023 | $4,377,715 | -93.4% | 40,111 | -93.2% | 0.01% | -91.3% |
| Q4 2022 | $66,641,280 | +117.6% | 585,600 | +18.3% | 0.10% | +119.1% |
| Q3 2022 | $30,628,000 | +3.8% | 494,856 | +33.7% | 0.05% | +67.9% |
| Q2 2022 | $29,514,000 | +2246.1% | 370,000 | +2994.4% | 0.03% | +2700.0% |
| Q1 2022 | $1,258,000 | +82.1% | 11,957 | +86.6% | 0.00% | – |
| Q4 2021 | $691,000 | -89.3% | 6,407 | -89.2% | 0.00% | -100.0% |
| Q3 2021 | $6,475,000 | -34.9% | 59,106 | -44.4% | 0.01% | -44.4% |
| Q2 2021 | $9,951,000 | -25.7% | 106,279 | -26.9% | 0.01% | -25.0% |
| Q1 2021 | $13,389,000 | +2.1% | 145,463 | -18.8% | 0.01% | +20.0% |
| Q4 2020 | $13,110,000 | +400.4% | 179,210 | +431.5% | 0.01% | +900.0% |
| Q3 2020 | $2,620,000 | – | 33,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |